These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
8. The use of segmental pressure index and transcutaneous oxygen tension in the diagnosis of peripheral arterial occlusive disease in geriatric patients. Wróblewski T, Hryszczykowa L. Mater Med Pol; 1991; 23(1):40-2. PubMed ID: 1843978 [Abstract] [Full Text] [Related]
9. [Conservative treatment of arterial occlusive diseases with naftidrofuryl hydrogen oxalate (author's transl)]. Ratschow R. MMW Munch Med Wochenschr; 1976 Sep 03; 118(36):1131-4. PubMed ID: 823407 [Abstract] [Full Text] [Related]
10. [Effect of naftidrofuryl on creatinine serum concentration and on PAH/inulin clearance in peripheral arterial occlusive diseases]. Heidrich VH, Baethke R, Beyer KH. Arzneimittelforschung; 1975 Mar 03; 25(3):429-31. PubMed ID: 1174049 [Abstract] [Full Text] [Related]
11. [Effect of intra-arterial and intravenous PGE1 infusions on transcutaneous oxygen pressure in patients with critical ischemia of the extremities]. Weiss T, Griesshaber J, Rogatti W, Kistner O, Hsu E, Jansen T, Diehm C. Vasa Suppl; 1991 Mar 03; 33():341-2. PubMed ID: 1788749 [Abstract] [Full Text] [Related]
13. [Transcutaneous oxygen partial pressure and systolic malleolar artery pressure in patients with peripheral arterial occlusive disease. Longitudinal measurements over 14 days]. Heidrich H, Lammersen T. Med Klin (Munich); 1993 Oct 15; 88(10):564-7. PubMed ID: 8272016 [Abstract] [Full Text] [Related]
14. Simvastatin effects in normo- and hypercholesterolaemic patients with peripheral arterial occlusive disease: a pilot study. Grodzińska L, Starzyk D, Bieroń K, Goszcz A, Korbut R. Basic Clin Pharmacol Toxicol; 2005 Jun 15; 96(6):413-9. PubMed ID: 15910404 [Abstract] [Full Text] [Related]
15. [Transcutaneous and intracutaneous pO2 measurements in the assessment of peripheral arterial occlusive diseases]. Reuter U, Setlak P, Petrow C, Altmann E, Sinz V. Z Gesamte Inn Med; 1987 Apr 01; 42(7):178-82. PubMed ID: 3604349 [Abstract] [Full Text] [Related]
17. [Consequences of obliterating arteriopathy of the legs on the professional activity of patients and external assistance]. Rolland N, Lebrun T, Comte S, Sailly JC. J Mal Vasc; 1999 Jun 01; 24(3):208-13. PubMed ID: 10467531 [Abstract] [Full Text] [Related]
18. tcpO2, arterial blood flow and lactate/pyruvate modifications induced by a single dose of naftidrofuryl IV during stage III lower-limb arteriopathies. Pointel JP, Thomas C, Mosnier M, Percebois G, Debry G. Angiology; 1986 Sep 01; 37(9):647-53. PubMed ID: 3767072 [Abstract] [Full Text] [Related]
19. Intra-arterial and intravenous administration of prostaglandin E1 cause different changes to skin microcirculation in patients with peripheral arterial occlusive disease. Thum J, Caspary L, Creutzig A, Alexander K. Vasa; 1998 May 01; 27(2):100-5. PubMed ID: 9612114 [Abstract] [Full Text] [Related]
20. The effect of naftidrofuryl on transcutaneous oxygen tension during a treadmill test in patients with peripheral arterial occlusive disease. Mouren X, Caillard P, Bensoussan JJ, Massonneau M, Gamand S, Stevens WH. Vasc Med; 1998 May 01; 3(1):9-14. PubMed ID: 9666526 [Abstract] [Full Text] [Related] Page: [Next] [New Search]